ARTICLE | Distillery Therapeutics
Cancer
October 18, 2018 6:39 PM UTC
Patient sample and mouse studies suggest T cell-specific inhibition of XBP1 or IRE1 could help treat ovarian cancer. In tumor and ascites samples from patients, high T cell expression of XBP1 was asso...